Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Lipids Health Dis ; 9: 77, 2010 Jul 24.
Artigo em Inglês | MEDLINE | ID: mdl-20653972

RESUMO

BACKGROUND: Dietary 1(3)-behenoyl-2,3(1)-dioleoyl-rac-glycerol (BOO) has been reported to inhibit pancreatic lipase activity in vitro and suppress postprandial hypertriacylglycerolemia in humans. In the present study, the anti-obesity activities of BOO and its inhibitory effects on lymphatic triacylglycerol (TAG) absorption were investigated in rats. METHODS: In Experiment 1, rats were fed either BOO or soybean oil (SO) diet for 6 weeks. In the BOO diet, 20% of SO was replaced with an experimental oil rich in BOO. In Experiments 2 and 3, rats cannulated in the thoracic duct were administered an emulsions containing trioleoylglycerol (OOO) or an oil mixture (OOO:BOO, 9:1). Tri[1-14C]oleoylglycerol (14C-OOO) was added to the emulsions administered in Experiment 3. RESULTS: No observable differences were detected in food intake or body weight gain between the BOO and SO groups in Experiment 1. Plasma and liver TAG concentrations and visceral fat weights were significantly lower in the BOO group than in the SO group. The apparent absorption rate of fat was significantly lower in the BOO group than in the SO group. In Experiment 2, the lymphatic recovery of oleic and behenic acids was significantly lower at 5 and 6 h after BOO administration than after OOO administration. In Experiment 3, the lymphatic recovery of 14C-OOO was significantly lower at 5 and 6 h after BOO administration than after OOO administration. CONCLUSIONS: These results suggest that BOO prevents deposition of visceral fat and hepatic TAG by lowering and delaying intestinal absorption of TAG.


Assuntos
Fármacos Antiobesidade/uso terapêutico , Ácidos Graxos , Absorção Intestinal , Obesidade/prevenção & controle , Ácido Oleico , Triglicerídeos/metabolismo , Triglicerídeos/uso terapêutico , Animais , Fármacos Antiobesidade/síntese química , Colesterol/sangue , Colesterol/metabolismo , Ingestão de Alimentos , Substitutos da Gordura/síntese química , Substitutos da Gordura/uso terapêutico , Ácidos Graxos/metabolismo , Fezes/química , Hipertrigliceridemia/sangue , Hipertrigliceridemia/prevenção & controle , Gordura Intra-Abdominal/patologia , Cinética , Fígado/metabolismo , Fígado/patologia , Linfa/metabolismo , Sistema Linfático/fisiologia , Masculino , Obesidade/sangue , Obesidade/dietoterapia , Obesidade/patologia , Ácido Oleico/metabolismo , Tamanho do Órgão , Ratos , Ratos Wistar , Triglicerídeos/sangue , Triglicerídeos/síntese química , Aumento de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...